ANAIS MALPICA to Protein Kinase Inhibitors
This is a "connection" page, showing publications ANAIS MALPICA has written about Protein Kinase Inhibitors.
Connection Strength
0.009
-
KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma. J Pathol. 2013 Dec; 231(4):449-56.
Score: 0.009
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.